Governance
Board of Directors and CommitteesOur Board of Directors comprises key industry players who are recognized for their expertise and come from biotech, big pharma, universities and the agri-tech sector, as well as representatives from Luxembourg Province and the Walloon Region!
Administrators on the Board of Directors of the CER Groupe
- BONTEMPS Philippe, Province du Luxembourg - Vice-President
- VANLOOCKE Olivier, CER Groupe - Administrator-Director
- BARET Philippe, UCL - Administrator
- BOUREZ Sophie, Wagralim - Administrator
- CASTILLO José, Univercells - Administrator
- DE BORMAN Béatrice, DIAsource ImmunoAssays - Administrator
- DENOEL Philippe, GSK Vaccines - Administrator
- DIVOY Christian, Agriculteur - Administrator
- GILLARD Dominique, Province du Luxembourg - Administrator
- GLATT Sophie, UCB - Administrator
- GRAVY Sophie, plusOne - Administrator
- MASSARD Christian, Province du Luxembourg - Administrator
- MOREAUX Benoit, QbD - Administrator
- SMETS Katelijne, ARSIA - Administrator
- VINCENT Stéphane, UNamur - Administrator
Observers on the Board of Directors of the CER Groupe
- BASTIAENS Annette, Walloon Region - Observer
- LEONARD Sophie, Walloon Region - Observer
- GORIELY Stanislas, ULB - Observer
Strategic Committee
The roles of the Strategic Committee are :
- define a strategy and propose an implementation plan to the Board of Directors
- monitor the execution of the strategic plan by the Management Committee
- monitor the development of the environment and correct the strategic plan if necessary
Members of the Strategic Committee :
- DENOËL Philippe - President Biowin & GSK
- BOUCHAT Jean-Claude - CEO ECI
- WALLEMACK Hugues - Exo Biologics
- DEMONTÉ Dominique - Brussels South Charleroi Biopark (BSCB)
- DECHAMPS Marc - Biowin, CEBR
- DESMECHT Daniel - ULg
- LIZIN Pascal - Board member in several companies
- VAN PUTTE Anthony - Pôle Mecatech
- VANLOOCKE Olivier - CEO of the CER Groupe
Audit Committee
The Audit Committee assists the Board of Directors in its oversight and monitoring duties in the following areas:
- the correct application of accounting principles, as well as any changes that may be made to them in the light of changes in legislation;
- the quality and efficiency of the financial reporting process ;
- the analysis of the Foundation's budget, annual accounts and consolidated accounts, including inter-subsidiary transfers, as well as the annual management reports and the auditor's reports on this subject Analysis and follow-up of any significant adjustments to be made on the recommendation of the auditor in the context of the statutory audit;
- the analysis of any interim financial statements and any other financial communications to third parties;
- the analysis of all other important accounting, tax and financial reporting issues, including the reporting of complex and/or non-routine transactions.
Members of the Audit Committee:
- GÉNARD Brigitte - Administrator
- MORRO Terry - CFO West Europe Omaya
- VANDEBROEK Jean-Luc - CFO Hyloris